Compared with nonusers， participants who regularly used aspirin after diagnosis experienced a multivariate hazard ratio (HR) for colorectal cancer–specific mortality of 0.71 (95% confidence interval [CI]， 0.53-0.95) and for overall mortality of 0.79 (95% CI, 0.65-0.97).
回复此楼
